Ocular toxoplasmosis and toxocariasis in childhood;Okuläre toxoplasmose und toxocariasis im kindesalter

Klinische Monatsblatter fur Augenheilkunde

Volumn 224, Issue 6, 2007, Pages 483-487

  Deuter, Christoph M E ^a   Garweg, J G ^b   Pleyer, U ^c   Schonherr U ^d   Thurau, S ^e  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b Swiss Eye Institute   (Switzerland)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Interne Abteilung   (Austria)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Childhood uveitis; Congenital infection; Ocular toxoplasmosis; Posterior uveitis; Toxocariasis

Indexed keywords

ALBENDAZOLE; ANTIBIOTIC AGENT; ATOVAQUONE; AZITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DIETHYLCARBAMAZINE; DOXYCYCLINE; FOLINIC ACID; MINOCYCLINE; PREDNISONE; PYRIMETHAMINE; PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN; TETRACYCLINE; TIABENDAZOLE;

CHORIORETINITIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ENDOPHTHALMITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; OPHTHALMOSCOPY; REVIEW; RISK FACTOR; SCAR; SYMPTOM; TOXOCARIASIS; TOXOPLASMOSIS; UVEITIS;

CHILD; HUMANS; TOXOCARIASIS; TOXOPLASMOSIS, OCULAR; UVEITIS;

EID: 34547129828     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963180     Document Type: Review

References (22)

1. Bertelmann E, Velhagen KH, Pleyer U et al. Okuläre Toxocariasis. Diagnostische und therapeutische Optionen. Ophthalmologe 2003; 100: 950-954
2. Bonfioli AA, Orefice F. Toxoplasmosis. Semin Ophthalmol 2005; 20: 129-141
3. Campos Jr D, Elefant GR, de Melo e Silva EO et al. Frequency of seropositivity to Toxocara canis in children of different socioeconomic strata. Rev Soc Bras Med Trop 2003; 36: 509-513
4. Despommier D. Toxocariasis: Clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev 2003; 16: 265-272
5. Garweg JG. Determinants of immunodiagnostic success in human ocular toxoplasmosis. Parasite Immunology 2005; 27: 61-68
6. Garweg JG, Kodjikian L, Peyron F et al. Kongenitale okuläre Toxoplasmose - Okuläre Manifestationen und Verlauf nach Frühdiagnostik der Infektion. Klin Monatsbl Augenheilkd 2005; 222: 721-727
7. Hill D, Dubey JP. Toxoplama gondii: transmission, diagnosis and prevention. Clin Microbiol Infect 2002; 8: 634-640
8. Holland GN. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol 2003; 136: 973-988
9. Holland GN. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol 2004; 137: 1-17
10. Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 2002; 134: 102-114. Erratum in Am J Ophthalmol 2002; 134: 944
11. Kishore K, Conway MD, Peyman GA. Intravitreal clindamycin and dexamethasone for toxoplasmic retinochoroiditis. Ophthalmic Surg Lasers 2001; 32: 183-192
12. Maguire AM, Green WR, Michels RG et al. Recovery of intraocular Toxocara canis by pars plana vitrectomy. Ophthalmology 1990; 97: 675-680
13. Nussenblatt RB. Ocular toxoplasmosis. In: Nussenblatt RB, Whitcup SM (Hrsg). Uveitis. Fundamentals and clinical practice. Elsevier, 2004; 3rd edition: 214-234
14. Nussenblatt RB. Toxocara canis. In: Nussenblatt RB, Whitcup SM (Hrsg). Uveitis. Fundamentals and clinical practice. Elsevier, 2004; 3rd edition: 244-249
15. Schiefke I, Schmäschke R, Ott R et al. Einheimische Helminthosen. Internist 2006; 47: 793-800
16. Shields JA. Ocular toxocariasis: a review. Surv Ophthalmol 1984; 28: 361-381
17. Silveira C, Belfort Jr R, Muccioli C et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 2002; 134: 41-46
18. Smith JR, Franc DT, Carter NS et al. Susceptibility of retinal vascular endothelium to infection with Toxoplasma gondii tachyzoites. Invest Ophthalmol Vis Sci 2004; 45: 1157-1161
19. Stewart JM, Cubillan LD, Cunningham Jr ET. Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina 2005; 25: 1005-1013
20. Torun N, Liekfeld A, Hartmann C et al. Okuläre Toxoplasmose-Antikörper in Kammerwasser und Serum. Ophthalmologe 2002; 99: 109-112
21. Torun N, Sherif Z, Garweg J et al. Management of ocular toxoplasmosis: A survey of members of the Uveitis Section of the German Ophthalmological Society (DOG). Manuskript zur Publikation eingereicht
22. Wallon M, Kodjikian L, Binquet C et al. Long-term ocular prognosis in 327 children with congenital toxoplasmosis. Pediatrics 2004; 113: 1567-1572